- Home
- OPHC vs SER Comparison
OPHC vs SER Comparison
Compare OPHC & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPHC
- SER
- Stock Information
- Founded
- OPHC 2000
- SER 2017
- Country
- OPHC United States
- SER United States
- Employees
- OPHC N/A
- SER N/A
- Industry
- OPHC Major Banks
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- OPHC Finance
- SER Health Care
- Exchange
- OPHC Nasdaq
- SER Nasdaq
- Market Cap
- OPHC 51.8M
- SER 56.5M
- IPO Year
- OPHC N/A
- SER 2018
- Fundamental
- Price
- OPHC $4.37
- SER $4.95
- Analyst Decision
- OPHC
- SER Strong Buy
- Analyst Count
- OPHC 0
- SER 2
- Target Price
- OPHC N/A
- SER $13.00
- AVG Volume (30 Days)
- OPHC 25.2K
- SER 305.6K
- Earning Date
- OPHC 08-07-2025
- SER 08-11-2025
- Dividend Yield
- OPHC N/A
- SER N/A
- EPS Growth
- OPHC 6.01
- SER N/A
- EPS
- OPHC 1.28
- SER N/A
- Revenue
- OPHC $41,269,000.00
- SER $130,000.00
- Revenue This Year
- OPHC N/A
- SER N/A
- Revenue Next Year
- OPHC N/A
- SER N/A
- P/E Ratio
- OPHC $3.42
- SER N/A
- Revenue Growth
- OPHC 36.79
- SER N/A
- 52 Week Low
- OPHC $3.53
- SER $3.81
- 52 Week High
- OPHC $5.90
- SER $10.28
- Technical
- Relative Strength Index (RSI)
- OPHC 49.83
- SER 41.16
- Support Level
- OPHC $4.21
- SER $4.71
- Resistance Level
- OPHC $4.42
- SER $7.92
- Average True Range (ATR)
- OPHC 0.08
- SER 0.54
- MACD
- OPHC 0.01
- SER -0.02
- Stochastic Oscillator
- OPHC 83.87
- SER 7.48
About OPHC OptimumBank Holdings Inc.
OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal accounts, money market deposit accounts, debit cards, and automated teller machines.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.